Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 4, 1998, Pages 315-321

  Sakane, Y ^a   Wada, H ^a   Kazuyo, H ^a   Shimura, M ^a   Nakasaki, T ^a   Katayama, N ^a   Nishikawa, M ^a   Deguchi, K ^a   Mori, Y ^c   Shiku, H ^a   Tahara, T ^b   Kato, T ^b  

^a MIE UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

^c Mie Red Cross Blood Center   (Japan)

Author keywords

ITP; Steroid therapy; TPO

Indexed keywords

THROMBOPOIETIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

EID: 15144347812     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199806000-00003     Document Type: Article

References (23)

1. George JN, El-Harase HA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994; 331: 1207-1211.
2. Dixon RH, Rosse WF. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. N Engl J Med 1975; 292: 230-236.
3. Mueller-Eckhardt C, Mueller-Eckhardt G, Kayser W, Voss RM, Wegner J, Küenzlen E. Platelet associated IgG, survival and platelet sequestration in thrombocytopenic states. Br J Haematol 1982; 52: 49-58.
4. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of magakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-538.
5. Bartley TD, Bogenberger J, Hunt P, Li Y-S, Lu HS, Martin F, et al. Identification and cloning of a magakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
6. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565-568.
7. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
8. Kato T, Ogami, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, et al. Purification and characterization of thrombopoietin. J Biochem 1995; 118: 229-236.
9. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
10. Nichol JL, Hokom MM, Hornkohl A, Sheridan WP, Ohashi H, Kato T, et al. Megakaryocyte growth and development factor: analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels durings chemotherapy-induced thrombocytopenia. J Clin Invest 1995; 95: 2973-2978.
11. Ulich TR, de Castillo J, Yin S, Swift S, Padilla D, Senaldi G, et al. Megakaryocyte growth and development factor ameliorates calboplastin-induced thrombocytopenia in mice. Blood 1995; 86: 971-976.
12. Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatome cell lines. Exp Hematol 1995; 23: 1388-1396.
13. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668-3675.
14. Tahara T, Usuki K, Sato H, Ohashi H, Monta H, Tsumura H, et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with hematopoietic disorders. Br J Haematol 1996; 93: 783-788.
15. Ichikawa N, Ishida F, Shimodaira S, Tahara T, Kato T, Kitano K. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anemia and idiopathic thrombocytopenic purpura. Thromb Haemost 1995; 76: 156-160.
16. Hiyayama K, Wada H, Shimura M, Nakasaki T, Katayama N, Nishikawa M, et al. Increased serum levels of thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coag Fibrinol 1997; 8: 345-349.
17. Tsubakio T, et al. Quantification of platelet-associated IgG with competitive solid phase enzyme immunoassay. Acta Haematol 1981; 66: 251-256.
18. Hoffman R, Mazur E, Bruno E, Floyd V. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med 1981; 305: 533-538.
19. Fielder PL, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, et al. Regulation of thrombopoetine levels by c-mpl-mediated binding to platelets. Blood 1996; 87: 2154-2161.
20. Emmons RVB, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996; 87: 4068-4071.
21. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 1992; 40: 167-170.
22. Wada H, Tamaki S, Tanigawa M, Takagi M, Mori Y, Deguchi A, et al. Plasma level of IL-1 in disseminated intravascular coagulation. Thromb Haemost 1991; 65: 364-368.
23. Chang M, Suen Yu, Meng G, Buzby JS, Bussel J, Shen V, et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia Insight into the regulation of platelet production. Blood 1996; 88: 3354-3362.